Cargando…

How ADA methodology informs SARS-CoV-2 assay development

Detalles Bibliográficos
Autor principal: Becker, Caroline
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Newlands Press Ltd 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7491572/
https://www.ncbi.nlm.nih.gov/pubmed/32915061
http://dx.doi.org/10.4155/bio-2020-0220
_version_ 1783582243816472576
author Becker, Caroline
author_facet Becker, Caroline
author_sort Becker, Caroline
collection PubMed
description
format Online
Article
Text
id pubmed-7491572
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Newlands Press Ltd
record_format MEDLINE/PubMed
spelling pubmed-74915722020-09-15 How ADA methodology informs SARS-CoV-2 assay development Becker, Caroline Bioanalysis Editorial Newlands Press Ltd 2020-09-11 2020-08 /pmc/articles/PMC7491572/ /pubmed/32915061 http://dx.doi.org/10.4155/bio-2020-0220 Text en © 2020 Newlands Press This work is licensed under the Creative Commons Attribution 4.0 License (http://creativecommons.org/licenses/by/4.0/)
spellingShingle Editorial
Becker, Caroline
How ADA methodology informs SARS-CoV-2 assay development
title How ADA methodology informs SARS-CoV-2 assay development
title_full How ADA methodology informs SARS-CoV-2 assay development
title_fullStr How ADA methodology informs SARS-CoV-2 assay development
title_full_unstemmed How ADA methodology informs SARS-CoV-2 assay development
title_short How ADA methodology informs SARS-CoV-2 assay development
title_sort how ada methodology informs sars-cov-2 assay development
topic Editorial
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7491572/
https://www.ncbi.nlm.nih.gov/pubmed/32915061
http://dx.doi.org/10.4155/bio-2020-0220
work_keys_str_mv AT beckercaroline howadamethodologyinformssarscov2assaydevelopment